Retrospective Study
Copyright ©The Author(s) 2024.
World J Diabetes. Jul 15, 2024; 15(7): 1509-1517
Published online Jul 15, 2024. doi: 10.4239/wjd.v15.i7.1509
Figure 1
Figure 1 Comparison of infarct morphology distribution maps between the two patient groups. A: Infarct morphology distribution maps of diabetic cerebral infarction group; B: Infarct morphology distribution maps of non-diabetic cerebral infarction group.
Figure 2
Figure 2 Distribution of arterial lumen stenosis rate in the two patient groups. A: Distribution of arterial lumen stenosis rate of diabetic cerebral infarction group; B: Distribution of arterial lumen stenosis rate of non-diabetic cerebral infarction group.
Figure 3
Figure 3 Receiver operating characteristic curve plot of magnetic resonance imaging combined with serum endostatin and galactagoglobin-3 for the diagnosis of diabetic cerebral infarction. Gal-3: Galactagoglobin-3; MR: Magnetic resonance.